Skip to main content
Equibles

MetLife Investment Management, LLC

Position in PGEN — Precigen, Inc.

CIK 1529735 Whippany, NJ
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$643,638
+$321,995 QoQ
Shares Held
112,919
+35.9% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 210 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. PGEN ranks #110 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in PGEN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $643,638 112,919
2026-03-31 $321,643 83,112
2025-12-31 $418,555 100,133
2025-09-30 $277,402 84,317
2025-06-30 $118,459 83,422
2025-03-31 $123,939 83,181
2024-09-30 $2,499 2,631
2024-06-30 $116,209 73,550
2024-03-31 $98,120 67,669
2023-12-31 $88,659 66,164
2023-09-30 $93,952 66,164
2023-06-30 $76,088 66,164
2023-03-31 $70,133 66,164
2022-12-31 $26,548 17,466
2022-09-30 $115,020 54,255
2021-12-31 $49,328 13,296
2021-09-30 $172,459 34,561
2021-06-30 $75,273 11,545
2021-03-31 $199,541 28,961
2020-12-31 $189,434 18,572
2020-09-30 $51,590 14,740
2020-06-30 $163,502 32,766
2020-03-31 $111,404 32,766